BioVie Announces Efficacy Data from Phase 3 Trial of
Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker...
United States Vastra Gotalands Lan Suzanne Hendrix Melyssa Weible Joseph Palumbo Elixir Health Public Relations
Source: globenewswire.com